newsfilter
← Latest News
GlobeNewswire·

MaxCyte to Acquire Akron Bio, Expanding its Offerings Across Cell Therapy Manufacturing and Expecting to Nearly Double Revenue Base

Akron Bio is a leading supplier of GMP-grade reagents and ancillary materialsExpands MaxCyte’s footprint across the cell therapy manufacturing workflow and establishes a combined portfolio supporting five commercially